Yeji
PDUFAoutcome: failureconf 0.99

reproxalap — PDUFA

$ALDX · Aldeyra Therapeutics, Inc. · dry eye disease
Event date
November 23, 2023
926 days ago
Sponsor runway
38 mo
$65.0M liquid

Evidence

In February 2023, the FDA accepted the reproxalap NDA for filing and set a Prescription Drug User Fee Act date of November 23, 2023.
Source: 8-K filed 2023-11-28View on EDGAR ↗0001193125-23-283679

Comparable historical pdufas· last 5 years · same indication

0% hit rate (0/1)
TickerDrugDateOutcome
$ALDXreproxalap2025-12-16unknown
$ALDXreproxalap2025-04-02failure

Recent insider activity· ±90 days

3 insiders · 0 buys · 2 sells
Sell
2023-10-18
PERCEPTIVE ADVISORS LLC
10%+ Owner
306,499 @ $1.74$533K
Sell
2023-10-16
PERCEPTIVE ADVISORS LLC
10%+ Owner
2,450,000 @ $1.60$3.92M
Exercise
2023-09-07
Brady Todd C
President and CEO
32,953 @ $0.55$18K
Exercise
2023-09-07
Brady Todd C
President and CEO
48,021 @ $0.55$27K
Tax
2023-09-07
Brady Todd C
President and CEO
73,807 @ $7.22$533K
Exercise
2023-09-07
Brady Todd C
President and CEO
192,084 @ $0.55$106K
Exercise
2023-09-07
Phillips Gary M.
Director
5,437 @ $0.55$3K